1059 related articles for article (PubMed ID: 25994453)
21. The role of hepatitis E virus infection in adult Americans with acute liver failure.
Fontana RJ; Engle RE; Scaglione S; Araya V; Shaikh O; Tillman H; Attar N; Purcell RH; Lee WM;
Hepatology; 2016 Dec; 64(6):1870-1880. PubMed ID: 27215797
[TBL] [Abstract][Full Text] [Related]
22. Seroprevalence of anti-hepatitis E antibodies and antigens among HIV-infected patients in Fars Province, southern Iran.
Shahriarirad R; Erfani A; Rastegarian M; Zeighami A; Arefkhah N; Ghorbani F; Sarvari J; Sarkari B
Virol J; 2020 Jul; 17(1):109. PubMed ID: 32680534
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of hepatitis E virus antibodies in patients with chronic hepatitis B and chronic hepatitis C.
Bayram A; Eksi F; Mehli M; Sözen E
Intervirology; 2007; 50(4):281-6. PubMed ID: 17570930
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis E Virus Superinfection and Clinical Progression in Hepatitis B Patients.
Hoan NX; Tong HV; Hecht N; Sy BT; Marcinek P; Meyer CG; Song le H; Toan NL; Kurreck J; Kremsner PG; Bock CT; Velavan TP
EBioMedicine; 2015 Dec; 2(12):2080-6. PubMed ID: 26844288
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis E Virus Seroprevalence Rate in HIV-Infected Patients in Germany: A Comparison of Two Commercial Assays.
Pischke S; Schwarze-Zander C; Bremer B; Lehmann P; Wiegand SB; Gisa A; Behrendt P; Strassburg CP; Manns MP; Wedemeyer H; Rockstroh JK
Intervirology; 2015; 58(5):283-7. PubMed ID: 26625157
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis E virus infection in HIV-infected patients: A large cohort study in Yunnan province, China.
Zhou S; Ren L; Xia X; Miao Z; Huang F; Li Y; Zhu M; Xie Z; Xu Y; Qian Y; Pan Q; Wang K
J Med Virol; 2018 Jun; 90(6):1121-1127. PubMed ID: 29457639
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis E virus in HIV-infected patients.
Renou C; Lafeuillade A; Cadranel JF; Pavio N; Pariente A; Allègre T; Poggi C; Pénaranda G; Cordier F; Nicand E;
AIDS; 2010 Jun; 24(10):1493-9. PubMed ID: 20467291
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis E virus infection in HIV-infected patients with elevated serum transaminases levels.
Sellier P; Mazeron MC; Tesse S; Badsi E; Evans J; Magnier JD; Sanson-Le-Pors MJ; Bergmann JF; Nicand E
Virol J; 2011 Apr; 8():171. PubMed ID: 21496215
[TBL] [Abstract][Full Text] [Related]
29. High prevalence of anti-hepatitis E virus antibodies among blood donors in central Italy, February to March 2014.
Lucarelli C; Spada E; Taliani G; Chionne P; Madonna E; Marcantonio C; Pezzotti P; Bruni R; La Rosa G; Pisani G; Dell'Orso L; Ragone K; Tomei C; Ciccaglione AR
Euro Surveill; 2016 Jul; 21(30):. PubMed ID: 27494608
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of hepatitis E virus RNA and antibodies in a cohort of kidney transplant recipients in Central Brazil.
de Oliveira JMNS; Freitas NR; Teles SA; Bottino FO; Lemos AS; de Oliveira JM; de Paula V; Pinto MA; Martins RMB
Int J Infect Dis; 2018 Apr; 69():41-43. PubMed ID: 29408465
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis E prevalence among HIV infected patients with elevated liver enzymes in the Netherlands.
Hassing RJ; van der Eijk AA; Lopes VB; Snijdewind IJ; de Man RA; Pas SD; van der Ende ME
J Clin Virol; 2014 Aug; 60(4):408-10. PubMed ID: 24929755
[TBL] [Abstract][Full Text] [Related]
32. HIV, HEV and cirrhosis: evidence of a possible link from eastern Spain.
Jardi R; Crespo M; Homs M; van den Eynde E; Girones R; Rodriguez-Manzano J; Caballero A; Buti M; Esteban R; Rodriguez-Frias F
HIV Med; 2012 Jul; 13(6):379-83. PubMed ID: 22257075
[TBL] [Abstract][Full Text] [Related]
33. High prevalence of antibodies against hepatitis E virus in HIV-infected patients with unexplained liver disease.
Merchante N; Parra-Sánchez M; Rivero-Juárez A; Cifuentes C; Camacho Á; Macías J; Martínez-Dueñas L; Pérez-Navarro E; Rivero A; Pineda JA
Enferm Infecc Microbiol Clin; 2015 Oct; 33(8):532-5. PubMed ID: 25533742
[TBL] [Abstract][Full Text] [Related]
34. Sero-epidemiology of hepatitis E virus (HEV) in urban and rural children of North India.
Mathur P; Arora NK; Panda SK; Kapoor SK; Jailkhani BL; Irshad M
Indian Pediatr; 2001 May; 38(5):461-75. PubMed ID: 11359972
[TBL] [Abstract][Full Text] [Related]
35. Four-year long (2014-2017) clinical and laboratory surveillance of hepatitis E virus infections using combined antibody, molecular, antigen and avidity detection methods: Increasing incidence and chronic HEV case in Hungary.
Pankovics P; Némethy O; Boros Á; Pár G; Szakály P; Reuter G
J Clin Virol; 2020 Mar; 124():104284. PubMed ID: 32007844
[TBL] [Abstract][Full Text] [Related]
36. Seroprevalence and risk factors of hepatitis E virus infection in cancer patients in eastern China.
Bai MJ; Zhou N; Dong W; Li GX; Cong W; Zhu XQ
Int J Infect Dis; 2018 Jun; 71():42-47. PubMed ID: 29656134
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and characteristics of hepatitis E virus infection in kidney transplant recipients: A single-center experience in Japan.
Nanmoku K; Owada Y; Oshiro Y; Kurosawa A; Kubo T; Shinzato T; Shimizu T; Kimura T; Sakuma Y; Ishikawa N; Ohkohchi N; Okamoto H; Yagisawa T
Transpl Infect Dis; 2019 Apr; 21(2):e13033. PubMed ID: 30481402
[TBL] [Abstract][Full Text] [Related]
38. Clinical and virological profiling of sporadic hepatitis E virus infection in China.
Wang L; Liu L; Wei Y; Wang Q; Tian Q; Wang L; Zhuang H
J Infect; 2016 Sep; 73(3):271-9. PubMed ID: 27343562
[TBL] [Abstract][Full Text] [Related]
39. Anti-hepatitis E virus antibody prevalence in French expatriate workers.
Vernier M; Rossi-Tamisier M; Richet H; Brouqui P; Parola P; Bouamri Y; Colson P; Gautret P
Int J Infect Dis; 2013 Nov; 17(11):e1082-4. PubMed ID: 23953700
[TBL] [Abstract][Full Text] [Related]
40. Past and current hepatitis E virus infection in renal transplant patients.
Hering T; Passos AM; Perez RM; Bilar J; Fragano D; Granato C; Medina-Pestana JO; Ferraz ML
J Med Virol; 2014 Jun; 86(6):948-53. PubMed ID: 24619955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
